1965
1 Den sneda muskelresultanten och rörelseaxeln. Hjortsjö C-H, Salford LG. Comm. from the Dept
of Anatomy, Univ. of Lund, 2 ,1965
1972-1981
2 Energy metabolism and histology in the brain during combined hypoxemia and ischemia. Salford
LG, Brierley JB, Plum F, Siesjö BK. Europ. Neurol. 6:329, 1972
3 A paradoxical EEG response during combined hypoxemia and unilateral carotid artery ligation in
the rat. Hougaard K, Plum F, Salford LG, Siesjö BK. Acta Physiol Scand. 86:568, 1972
4 Optimal freezing conditions for cerebral metabolites i rats. Ponté n U, Ratcheson RA, Salford LG,
Siesjö BK. J. Neurochem 21:1127, 1973
5 Moderate hypoxic ischemia irreversibly damages rat brain in 30 minutes. Brierley JB, Salford LG,
Siesjö BK, Plum F. Stroke 4:339, 1973
6 Altered cerebral metabolites and blood flow in response to physiological stimulation. Salford LG,
Duffy TE, Plum F. Stroke 4:361, 1973
7 Graded Hypoxia-oligemia in rat brain. I. Biochemial alterations and their implications. Salford
LG, Siesjö BK, Plum F. Arch Neurol 29:227, 1973
8 Graded Hypoxia-oligemia in rat brain. II. Neuropathological alterations and their implications.
Salford LG, Plum F, Brierley JB. Arch Neurol 29:234, 1973
9 Cerebral energy metabolism and the regulation of cerebral blood flow. Howse D, Plum F, Duffy
TE, Salford LG. Trans Amer Neurol Ass. 1973
10 Metabolic state and blood flow in rat cerebral cortex, cerebellum and brainstem in hypoxic
hypoxia. Macmillan V, Salford LG, Siesjö BK. Acta Physiol Scand. 92:130, 1974
11 The influence of arterial hypoxia and unilateral carotid artery occlusion upon regional blood flow
and metabolism in the rat brain. Salford LG, Siesjö BK. Acta Physiol Scand. 92:130, 1974
12 Influence of profound hypoxia on regional metabolism, blood flow and cell morphology in rat
brain. Doktorsavhandling, Lunds Universitet. 1974
13 Irreversible brain damage produced by hypoxemia. Salford LG, Brierley JB, Plum F, Siesjö BK.
In Cerebral Circulation and Metabolism. (Ed. Langfitt ThW). Springer Verlag. 163, 1975
14 Association of blood flow and acid-base change in brain during afferent stimulation. Salford LG,
Duffy TE, Plum F. in Cerebral Circulation and Metabolism. (Ed Langfitt ThW) Springer Verlag.
380, 1975
15 Hypoxia and cerebral metabolism. Siesjö BK, Norberg K, Ljunggren B, Salford LG. Textbook
chapter in "A basis and practice of neuroanesthesia" (Ed. Gordon E.) 47, 1975
16 Brain function, metabolism and blood flow in moderate and severe arterial hypoxia. Siesjö BK,
Johannsson H, Norberg K, Salford LG in "Brain Work", Alfred Benzon Symposium VIII,
Munksgaard 1975
17 Neuropatologin i kliniken. Thulin C-A, Salford LG. Lä kartidningen 49:4316, 1976
18. Redundant nerve roots of the cauda equina. (A report of five cases). Thulin C-A, Edner G,
Fodstad H, Salford LG, Svendgaard N-Aa. Acta Neurochir 41:115-125, 1978
19 Extra-intracranial arterial by-pass surgery in completed stroke patients. Criteria for selection and
preliminary clinical results. Salford LG, Abdul-Rahman A, Svendgaard N-Aa, Thulin C-A. Acta
Neurochir 42:249, 1978
20 Impact of CT in the neurosurgical management of intracranial tumors. Brismar J, Strömblad L-G,
Salford LG. Neuroradiology 16:506-509, 1978
21 The influence of late arterial spasm on CBF and its response to a Ca-uptake inhibitor. Sahlin Ch,
Brismar J, Ljunggren K, Owman Ch, Rodacki MA, Salford LG, Svendgaard N-Aa. Acta Neurochir
51:128, 1979
22 Late arterial cerebral spasm: its influence on CBF, CMRO2 and its response to a calcium transport
inhibitor and intrathecal amine antagonists. Svendgaard N-Aa, Brismar J, Owman Ch, Sahlin Ch,
Salford LG. Acta Neurol Scan Suppl 72, 60:510-511, 1979
23 Intratumoral administration of interferon in malignant gliomas. Salford LG et al. Acta Neurochir
56(1-2): 130-31, 1981
24 The effect of a Ca-transport inhibitor on CBF and CMRO2 in late cerebral arterial spasm in
baboons. Sahlin Ch, Brismar J, Delgado T, Owman Ch, Salford LG, Svendgaard N-Aa. Acta
Nerochir 56:133-136, 1981
25 Magnetiska mikrosfärer för anrikning av läkemedel. Schröder U, Mosbach C, Salford LG. Sv.
Läkaresällsk. handlingar 1980
26 Anrikning av magnetiskt material i råtthjärna. Salford LG, Brun A, Mosbach C, Schröder U. Sv.
Läkaresä llsk. Handlingar 1980
27 Intratumoral and systemic interferon treatment of astrocytomas grade III-IV. Salford LG,
Borgström S, Brismar J, Brun A, Cronqvist S, Flodgren P, Lindahl SÅ , Nordström CH, Olivecrona H,
Sandberg M, Stenstam B, Strömblad L-G. The US-Japanese Conf on Brain Tumor Therapy, Nikko,
Japan, Oct 1981
28 Intratumoral och generell interferonbehandling av astrocytom grad III-IV. Strömblad LG, Brun A,
Nordström CH, Salford LG and Sandberg M. Sv. Läkaresä llsk. Handlingar 1981
1982
29 Laserkirurgi. Laser i Neurokirurgi. Thulin C-A, Salford LG, Lundquist SB. Läkartidn. Vol 79, Nr
45:1169-1170, 1982
30 Late cerebral arterial spasm: The cerebral arterial response to hypercapnia, induced hypertension
and the effect of nimodipine on CBF autoregulation in experimental SAH in primates. Svendgaard NAa, Brismar J, Delgado T, Owman Ch, Sahlin Ch, Salford LG. The First International Symposium on
Pharmacology of Human Blood Vessels. Kuwait 16-18 Jan. 1982
31 Acute management of head injuries. Handbook for surgeons. Salford LG. Textbook. The Kuwait
Board for Traumatology, Kuwait, 1982
32 Treatment of severe cervical spine injuries using anterior interbody fusion with early mobilisation.
Svendgaard N-Aa, Cronqvist S, Salford LG, Acta Neurochir 60:91-105, 1982
33 A model for xenotransplantation of human malignant astrocytomas into the brain of normal adult
rats. Strömblad LG, Brun A, Salford LG, Stenevi U. Acta Neurochir 65:217-226, 1982
1983
34 Topical versus systemic human leukocyte interferon treatment. Oster K, Salford LG, Hornmark-
Stenstam B, Flodgren P, Stöyer-Cristophersen I, Magnusson K and the Southern Sweden
Neurooncology Group. In "The Biology of the Interferon System" Elsevier, Holland 1983
35 Mikrokirurgi - aktuella och framtida användningsområden. Salford LG, Svendgaard N-Aa.
Läkartidningen. 1983
36 Late cerebral arterial spasm: the cerebrovascular response to hypercapnia, induced hypertension
and the effect of nimodipine on blood flow autoregulation in experimental subarachnoidal hemorrhage
in primates. Svendgaard N-Aa, Brismar J, Delgado T, Egund N, Owman Ch, Rodacki M, Salford LG.
General Pharmacology Vol 14, Nr 1:167-172, 1983
37 Magnetisk styrning av läkemedel. Schröder U, Salford LG. I "Cancerforskning - en nyckel till liv".
Presentationer vid Forskningens Dag, Lund nov 1983
38 Crystallized carbohydrate spheres with entrapped biologically active substances for slow release
and targeting. Schrö der U, Salford LG, Stå hl A, Mosbach K. The International Congress on
Microspheres and Drug Therapy, Amsterdam 1983
39 Patentansökan nr 8307060-7. "Diagnostikum och kontrastmedel". Schröder U och Salford LG.
Godkänt Svenskt patent. Uppfinning av kontrastmedel för MRI. 1983
1984
40 Sturge-Weber disease - Neurophysiological evaluation of a case with secondary epileptogenesis,
successfully treated with lobe-ectomy. Rosén I, Salford LG, Starck L. Neuropediatrics 15:95-98,
1984
41 Behandlingsprogram för astrocytom grad III-IV. Onkologiskt Centrum, Lund, 1981-86
42 Ny behandling av maligna hjärntumörer ger ökad medelöverlevnad men ej bot. Salford LG, Strö
mblad L-G. Medicinsk rapport frå n Brain Tumor Research and Therapy Conference i Asilomar,
Californien, okt 1983. Läkartidn 12:1158-59, 1984
43. Crystallized carbohydrate spheres for slow release, drug targeting and cell separation. Schröder
U, Ståhl A and Salford LG.. Textbook chapter in "Microspheres ancdDrug Therapy". Ed. Tomlinson
E. Elsevier Biomedical Press. p. 427-435. Amsterdam 1984
44 The use of paramagnetic and ferromagnetic substances as contrast agent in NMR-imaging of T1
and T2 respectively. Olsson M, Persson B, Salford LG, Schröder U. 1st Congress of the European
Society for Magnetic Resonance in Medicine and Biology, Geneva, Switzerland. 1984
45 Paramagnetiska och ferromagnetiska ämnen som kontrastmedel i T1 resp T2 NMR-bilder (NMRimaging). Svenska Läkaresällskapets Handlingar 1984
1985
46 Chemotherapy (CCNU+Vincristine+Procarbazine) +/- Radiotherapy in Astrocytoma Grade III and
IV. Malmströ m P, Sandberg M, Borgströ m S, Brun A, Cronqvist S, Salford LG, Strömblad L-G.
Proceedings of ASCO, Vol 4:142, 1985
1986
47 Vasomotor responses of cerebral veins in animals and man. Hardebo J-E, Kå hrströ m J,
Sercombe R, Owman Ch, Salford LG, Verreccia C. In Neuronal regulation of Brain Circulation.
Fernström Foundation Series, Vol 8. (Ed. by C. Owman & J-E Hardebo). Elsevier Biomedical Press,
Amsterdam, 1986
48 Ferromagnetic particles as contrast agent in T2 NMR-imaging. Olsson M, Persson B, Salford LG,
Schrö der U. Mag Reson Imaging Vol 4, nr 5, 1986
49 Elemental regional distribution in human brain tumours - PIXE analysis of biopsy samples
obtained during neurosurgery. Tapper UAS, Malmqvist KG, Salford LG, Brun A. Proceedings 4th
International PIXE-Conference. Thallahassee, Florida. 1986
50 Xenotransplantation of human astrocytomas grade II-IV into the brain of normal and Cyclosporin
A treated adult rats. Salford LG, Brun A. Tenth Int Congress of Neuropathol. Stockholm 1986. p
251.
1987
51 Endothelium-dependent relaxation by uridine tri- and diphosphate in isolated human pial vessels.
Hardebo JE, Kå hrströ m J, Owman Ch, Salford LG. Blood Vessels 24:150-155, 1987
52 Elemental regional distribution in human brain tumours - PIXE analysis of biopsy and autopsy
samples. Tapper UAS, Malmqvist KG, Brun A, Salford LG. Nuclear Instruments and Methods in
Physics Research B22:176-178, 1987
53 Cerebrovascular and metabolic changes during the delayed vasospasm following experimental
subarachnoid hemorrhage in baboons, and treatment with a calcium antagonist. Sahlin Ch, Brismar J,
Delgado T, Owman Ch, Salford LG, Svendgaard N-Aa. Brain Res 403:313-332, 1987
54. Acute management of head injuries. Textbook, 2nd ed. Salford LG. The Kuwait Board for
Traumatology, Kuwait. 1987.
55. Experimental gliomas, cell culture. Salford LG. European Association of Neurosurgical
Societies, Wroclaw, Polen. In Druk "Cuprum", Zam. KLinika Neurochirurgii nr 402/87 egz 350 C-4.
1987.
56. Vasomotor effects of neurotransmitters and modulators on isolated human pial veins. Hardebo
JE, Kåhrströ m J, Owman Ch and Salford LG,. J. CBF Metab. 7:612-618, 1987.
Locus Medicus Lundensis, kapitel i ”Läkaresällskapet i Lund 1962 – 1987” Minnesskrift vid
Sällskapets 125-årsjubileum. Sydsvenska Medicinhistoriska Sällskapets Årsskrift, suppl 8, 1987
Carl Gustaf Ahlström och Leif G. Salford
1988
57. Maligna gliom - terapi? Pontén J, Hedstrand H, Malmström P, Salford LG and Westermark B.
Lä kartidningen 1988.
58. Affective and cognitive changes in brain tumor patients before and after surgery related to rCBF.
Nilsson Å , Hagstadius S, Risberg J, Salford LG and Smith G. J. Clin. Exp. Neuropsychol. Vol 11. Nr
1. 1988.
59. Proton microprobe and PIXE analysis for studies of pathological brain tissue. Malmqvist KG,
Brun A, Imamura K, Martins E, Salford LG, Siesjö BK, Tapper UAS and Themner K. Scanning
Microscopy 2 (3): 1685-1693, 1988.
60. DNA content in human astrocytomas and surrounding brain tissue. Salford LG, Baldetorp B,
Brun A, Hallencreutz G and Stenstam B. Acta Neurochir. 91:162-163, 1988.
61. Ten year survival among patients with supratentorial astrocytoma grade III and IV. Salford LG,
Brun A and Nirfalk S. J. Neurosurg. 69:506-509, 1988.
62. Clinical recording of laser-induced autoflourescence spectra for evaluation of tumour
demarcation feasibility in selected clinical specialities. Andersson-Engels S, Elner Å , Johansson J,
Karlsson SE, Salford LG, Strö mblad LG, Svanberg K and Svanberg S. Photodynamic Therapy and
Medical Laser Applications, 1988.
63. Astrocytoma grade III and IV. Malmström P, Sandberg M, Salford LG, Strö mblad LG, Borgströ
m B, Brun A and Cronquist S. The Oncological Centre in Southern Sweden. Ten years experience
1978-88. Lund 1988.
64. Laser Flourescence diagnostics of tissue. Andersson-Engels S, Ankerst J, Brun A, Elner Å ,
Gustafsson A, Johanson J, Karlsson SE, Killander D, Kjellé n E, Lindstedt E, Montan S, Salford LG,
Simonsson B, Stenram U, Strö mblad LG, Svanberg K and Svanberg S. Invited paper "Lasers in Life
Sciences". Heidelberg, 29/8 - 1/9, 1988.
65. Anxiety, coping strategies and regional cerebral blood flow in brain tumor patients before and
after surgery: A dynamic approach. Lilja Å , Hagstadius S, Risberg J, Salford LG and Smith G.
Psychol. Res. Bull. 28 (3-4):1-28, 1988.
1989
66. Adenosine diphosphate ribosyl transferase in the mononuclear leukocytes of patients with brain
tumours. Salford LG and Pero RW. British Journal of Neurosurgery. Vol 3 (2): 248, 1989.
67. Adenosine Diphosphate Ribosyl Transferase response to a standardized dose of hydrogen
peroxide in the mononuclear leukocytes of patients with a diagnosis of cancer. Pero RW, Johnson D,
Miller D, Zang E, Markowitz M, Doyle G, Lund-Pero M, Salford LG, Sordillo P, Raskin N and
Beattie E. Carcinogenesis 10:1657-1664, 1989.
68. Endothelin is a potent constrictor of human cerebral arteries. Hardebo J-E, Kåhrström J, Owman
C and Salford LG. Blood Vessels. 26:249-253. 1989.
69 P15E, an immunosuppressor in malignant gliomas. Salford LG, Lindvall M, Siesjö P and Sjögren
O. J. of Neuro-Oncology 7:S24, 1989.
70. Interactions of low level combined static and extremely low frequency magnetic fields with
calcium ion transport in normal and transformed human lymfocytes and rat thymic cells. Persson B,
Malmgren L, Carlsson KÅ , Lindvall M, and Salford LG. Interaction mechanisms of low-level
electromagnetic fields in living systems - resonant phenomena. Royal Swedish Academy of Sciences.
1989.
71. Tissue diagnostics using laser-induced flourescence. Andersson-Engels S, Ankerst J, Brun A,
Elner Å , Gustafsson A, , Karlsson SE, Killander D, Kjellen E, Lindstedt E, Montan S, Salford LG,
Simonsson B, Stenram U, Strömblad LG, Svanberg K and Svanberg S. Ber. Bunsenges. Phys. Chem.
93:335-342, 1989.
72. Frontal lobe dysfunction in brain tumor patients before and after surgery. Salford LG, Hagstadius
S, Lilja Å , Risberg J and Smith G. Journal of Cerebral Blood Flow and Metabolism. Vol. 9. Suppl 1.
1989.
73. Identification of brain tumours in rats using laser-induced fluorescence and haematoporphyrin
derivative. Andersson-Engels S, Brun A, Kjelle'n E, Salford LG, Strömblad LG, Svanberg K and
Svanberg S. Lasers in Med. Science. 4: 1989
74. Endothelin, a potent endothelium-derived constrictor of cerebral vessels. Possible contribution to
cerebrovascular disturbances in hypertension. Hardebo J.E, Kå hrströ m J, Owman C and Salford LG.
in Seylaz, Sercombe, Neurotransmission and Cerebrovascular Function, Vol 2, (Elsevier, Amsterdam)
1989.
75. Interaction of combined static and extremely low frequency magnetic fields with calcium ion
transport in normal and transformed human lymfocytes and rat thymic cells. Persson B, Lindvall M,
Malmgren L and Salford LG. In Charge and Field Effect in Biosystems. II. Ed. M.J. Allen, Plenum
Press. 1989.
76. Trisomy 7 and sex chromosome loss in human brain tissue. Heim S, Mandahl N, Yuesheng J,
Strömblad S, Lindström E, Salford LG and Mitelman F. Cytogenet. Cell Genet. 52.136-138, 1989.
1990
77. Colloid cysts of the third ventricle. Correlation of MR and CT findings with histology and
chemical analysis. Maeder PP, Holtås SL, Basibü yü k LN, Salford LG, Tapper UAS and Brun A.
Am. J. Radiol. 11:575-581. 1990
78. Hydra Head Activator-like immunoreactivity in Astrocytomas grade III-IV and the surrounding
brain tissue. Ekman R, Salford LG, Brun A and Larsson I. Peptides 11:271-275, 1990.
79. Changes in contractile response and effect of a calcium antagonist, Nimodipine in isolated
intracranial arteries of baboon following experimental subarachnoid haemorrhage. Sahlin Ch, Owman
Ch, Delgado T, Chang J-Y, Salford LG and Svendgaard NAa. Brain Res Bull 24:355-361, 1990
80. Cloning and characterization of tumor infiltrating T-cells in human gliomas. Lindvall M, Salford
LG and Sjögren HO. J. of Cellular Biochemistry. Suppl. 14B. Wiley-Liss, Inc. New York. 1990.
81. Permeability of the Blood-Brain Barrier (BBB) of the rat to albumin is not significantly altered
by Nuclear Magnetic Resonance Imaging (NMRI) Fields. Ross SR, Liburdy RP, Budinger TF, Salford
LG, Brun A, Persson BRR, Roos MS, deManincor DJ and Brennan KM.
The Bioelectromagnetics Society, San Antonio, Texas, 1990.
82. Role of endothelium in the response of human intracranial arteries to slight magnesium
deficiency. Csaba Szabó , Jan-Erik Hardebo, Leif G. Salford. Rapid communication in Acta Physiol.
Scand. 1990
1991
83. Clinical recording of laser-induced flourescence spectra for evaluation of tumour demarcation
feasibility in selected clinical specialities. Andersson-Engels S, Elner Å , Johanson J, Karlsson S-E,
Salford LG, Strömblad L-G, Svanberg K and Svanberg S. Lasers in Medical Science 6:415-424, 1991
84 In vivo evidence in humans of an association between ADP-ribosylation levels in mononuclear
leukocytes and immune function.
Pero R.W., Olsson H., Salford LG and Troll W. Acc for publ. in Proceedings from the 9th
International Meeting on ADP-ribose reactions. Poirer G and Moreau P (eds) Springer Verlag, NY.
1991
85 Circadian variation of body temperature in man. Johansson, BW, Kristiansson KA,
Papadopoulos I, Salford LG, Sporrong B. In:Thermoregulation (eds Lomax and Schö nbaum) Karger
AG, Basel. pp 84-87, 1991
86. Lack of neural control and reactivity to vasoactive agents in malignant glioma arteries. Hardebo
J-E, Kåhrström J and Salford LG. J. Neurosurg 74:633-635, 1991
87. A randomized study of chemotherapy with procarbazine, vincristine and CCNU with and
without radiotherapy for astrocytoma grades 3 and/or 4
Sandberg M, Malmström P, Strömblad S, Borgström S, Brun A , Cronqvist S., Houggaard, Salford
LG. Cancer 68:22-29, 1991.
88.. Trisomy 7 and numerical sex chromosome aberrations are not representative of tumor
parenchyma cells in malignant glioma. Lindströ m E, Salford LG, Heim S, Mandahl N, Strö mblad S,
Brun A, Mitelman F.
Genes, Chromosomes & Cancer 3:474-479, 1991
89. Pattern recognition by the use of multivariate statistical evaluation of macro- and micro-PIXE
results. Tapper UAS, Lö vestam NEG, Swietlicki E, Malmqvist KG and Salford LG. Nucl. Instr. and
Methods in Physics Research B24:191-196, 1991
90. Undersökning av frontallobssystemets funktioner (i ett evolutionistiskt perspektiv) . Lilja Å ,
Nilsson I-L, Salford LG, Andersson I.
Psykologiförlaget 1991.
91 Increased permeability of the blood-brain-barrier induced by magnetic and electromagnetic fields.
Persson BRR, Salford LG, Brun A, Eberhardt J and Malmgren L. In Proc. "Biological Effects and
Safety Aspects of Nuclear Magnetic Resonance Imaging and Spectroscopy". The New York Academy
of Sciences, 1991
1992
92. Metoclopramide as a sensitizer of 1,3-BIS(2-Chloroethyl)-1- Nitrosourea (BCNU) treatment of
brain tumors in the rat. Salford LG , Pero RW, Aas AT, Brun A. Anticancer drugs. 3:267-272, 1992
93. Role of endothelium in the responses of human intracranial arteries to a slight reduction of
extracellular magnesium. Csaba Szabó , Jan-Erik Hardebo, Leif G. Salford. Experimental Physiology
77:209-211, 1992
94. Bakgrund om maligna gliom. Faktaruta för Läkartidningen,89 (49):4284, 1992. Salford LG.
95. Fosfolipidkonjugerat cytosinarabinosid. Cellulärt upptag och omsättning av ett potentiellt
cytostaticum i terapin mot maligna gliom.
Lohman N, Alling Ch, Chattopadhyaya Y, Ponté n J, Salford LG. Rapport till RmC.
96. A quantitative study on biokinetics and biodistribution of BSH in a rat glioma model. Hemler
RBJ, Ceberg CP, Brun A, Gabel D, Larsson B, Persson BRR and Salford LG. In: Neutron Capture
Therapy for Cancer. Plenum Press, New York, ISBN 0-306-441047-7, pp 469-473, 1992.
97. Macroscopic and microscopic biodistribution of BSH in a rat glioma model. Ceberg CP, Persson
A, Brun A, Jergil B, Persson RBR and Salford LG. in Towards Clinical Trials of Glioma with BNCT.
Plenum Press, New York, ISBN 0-306-44350-3. pp 175-78, 1992
98.. Electromagnetic field induced permeability of the Blood Brain Barrier in rat, shown by immunohistochemical methods. Salford, L.G., Brun, A., Persson, R.B.R. In "Interaction mechanisms of lowlevel electromagnetic fields in living systems - resonant phenomena and other effects" (ed. Nordé n
and Ramel). Oxford Press p. 251-258, 1992
99. Retrovirus expression in human gliomas studied at protein and RNA level. Salford LG,
Blomberg J, Lindvall M, Medstrand P, Sjögren H-O and Widegren B. J. Neurooncology, 12(3):284,
1992
100. EMF interaction with calcium-45 transport in biomembranes. Persson RBR, Salford LG,
Eberhardt JL, Sommarin M. Nanobiology vol 3: 483-490, 1992
101. Frontal lobe dynamics in brain tumor patients: A study of regional cerebral blood flow and
affective changes before and after surgery. Lilja Å , Hagstadius S, Risberg J, Salford LG and Smith G.
Neuropsychiatry, Neuropsychology and Behavioural Neurology. 4:294-300, 1992
102. Thallium-201 and SPECT distinguishes high-grade from low-grade gliomas. Sjö holm H, Brun
A, Elmqvist D, Rehncrona S, Rosé n I, Salford LG J. Nucl Med 33:868, 1992
103. Simulation of the effect of inhomogenities in TEM transmission cells using the FDTD-method
Van Hese J, Martens L, De Zutter D, De Wagter C, Malmgren LOG, Persson BRR, Salford LG IEEE
Transactions on Electromagnetic Compatibility 34:292-298, 1992
104. Microprocesses in perception and personality. Lilja Å , Smith G, Salford LG. J. Nerv and Ment
Dis 180:82-88, 1992.
105. Interaction of low-level combined static and extremely low frequency magnetic fields with
calcium ion transport in normal and transformed human lymfocytes and rat thymic cells. Persson
BRR, Lindvall M, Malmgren L, and Salford LG. in " Interaction mechanisms of low-level
electromagnetic fields in living systems - resonant phenomena and other effects". Oxford Press p. 199209, 1992
106 Mononuclear leukocyte ADP-ribosylation as an indicator of immune function in malignant
glioma patients treated with betamethasone for cerebral edema. Pero RW, Salford LG, Strömblad LG,
Andersson C. J of Neurosurgery 77:601-606, 1992
1993
107. RG2 rat glioma model: influence of the blood-brain-barrier on biodistribution of
boronsylfhydryl. Schuepbach D, Gavin PR, Salford LG, Ceberg C and Fankhauser H. in: "Advances
in Neutron Capture Therapy", Ed. Soloway et al.Plenum Press, New York 485-490, 1993
108. A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Salford
LG, Persson BRR, Brun A, Ceberg C, Kongstad PC and L. Mir. Biochem. Biophys. Res. Commun.
Vol 194, 2 :938-943, 1993
109. Neutron capture imaging of 10B in tissue specimens. Ceberg C, Salford LG, Brun A, Hemler
R, and Persson BRR. J Radiotherapy and Oncology 26:139-146, 1993
110. Experimental studies of brain tumour development during exposure to continuous and pulsed
915 MHz radiofrequency radiation. Salford LG, Brun A, Eberhardt JL and BRR Persson.
Bioelectrochemistry and Bioenergetics, 30:313-318, 1993.
111. Permeability of the blood-brain barrier in rats induced by radiofrequency EM-radiation,
continuous-wave and modulated at 8, 16, 50 and 200 Hz. Salford LG, Brun A, Eberhardt JL and BRR
Persson. Bioelectrochemistry and Bioenergetics, 30:293-301, 1993.
112. Beta camera low activity tumor imaging. Ljunggren K, Strand S-E, Ceberg CP, Sjöholm H,
Elmqvist D, Brun A and Salford LG. Acta Oncologica 32(7/8):869-872, 1993.
113. Immunization with mutagen treated tum- cells causes rejection of nonimmunogenic rat glioma.
Siesjö P, Visse E, Lindvall M, Salford LG, Sjögren HO. Cancer Immunol and Immunother 37:67-74,
1993
114. Experimental studies of brain tumor development during exposure to continuous and pulsed
915MHz radiofrequency radiation. Salford LG, Brun A, Eberhardt JL, Persson BRR. Electricity and
magnetism in biology and medicine. (Ed.: Martin Blank) San Francisco Press. pp 379-381, 1993
115. Reoperation for malignant astrocytomas. Own experience and review of the literature. Strömblad
L-G, Andersson H, Malmström P and Salford LG. British J of Neurosurg 7:623-633, 1993
116. In vivo flourescence spectra of malignant lesions in various clinical specialities. AnderssonEngels S, Berg R, Colleen S, Johanson J, Karlsson S-E, Lundgren R, Salford LG, Strömblad L-G,
Svanberg K and Svanberg S. In: P Spinelli, M Dal Fante, R Marchesini (eds) Photodynamic Terapy
and Medical Lasers. p 871-875, Excerpta Medica, Amsterdam 1993.
117. Permeability of the blood/brain barrier induced by 915 MHz EM radiation (CW and modulated)
at various SARs.. Salford LG, Brun A, Eberhardt JL, Persson BRR. Electricity and magnetism in
biology and medicine. (Ed.: Martin Blank) San Francisco Press. pp 599-602, 1993
118. Theoretical verification of microwave exposure experiments on small animals and cell cultures
in a TEM cell. Martens L, van Hese J, de Zutter D, Malmgren L, Persson BRR, Salford LG. In
Radiation Research, A Twentieth Century Perspective (eds Chapman JD, Dewey WC, Whitmore GF)
Vol 1, PO3,27SP, Academic Press Inc. San Diego CA, 1993
119. Electromagnetic field calculations used for exposure experiments on small animals in TEM-
cells Martens L, van Hese J, de Zutter D, de Wagter C, Malmgren L, Persson BRR, Salford LG
Bioelectrochemistry and Bioenergetics, 30:73-81, 1993
1994
120. Permeability of the Blood-Brain-Barrier induced by 915 MHz electromagnetic radiation, continuous wave
and modulated at 8, 16, 50 and 200 Hz. Salford LG, Brun A, Eberhardt JL, Persson BRR. J of Electron
Microscopy and Technique Vol 27:535-542, 1994
121. Quantitative boron measurements in tissue specimens. Ceberg CP, Salford LG and Persson RBR. CLINCT
BNCT Workshop Helsinki 1993 (ed Iiro Auterinen and Merja Kallio). TKK-F-A718, ISBN 951-22-1980-8, p
136-139, 1994
122. Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth. Alf Tore Aas, Arne
Brun, Ronald W. Pero and Leif G. Salford Br J of Neurosurgery 8:187-192, 1994
123. Reduced formation of high molecular weight DNA in murine gliomas treated with nitrosourea and
chlorpromazine. Aas AT, Salford LG, Lönn S and Lönn U. Anticancer Research 14:1133-1136, 1994
124. Enhanced boron uptake in RG 2 rat gliomas by electropermeabilization in vivo . Ceberg C, Brun A, Mir
LM, Persson BRR and Salford LG. Anti-Cancer Drugs 5:463-466, 1994
125. Permeability of the Blood-Brain-Barrier induced by 915 MHz electromagnetic radiation, continuous wave
and modulated at 8, 16, 50 and 200 Hz. Salford LG, Brun A, Eberhardt JL, Persson BRR. J of Electron
Microscopy and Technique Vol 27:535-542, 1994
126. Human Endothelin ETA receptor antisense oligodeoxynucleotides inhibit endothelin-1 evoked
vasoconstriction. Adner M, Erlinge D, Salford LG, Yee F, Wahlestedt C, Edvinsson L. Eur J Pharmacol
261:281-4, 1994
1995
127. SPECT imaging of gliomas with Thallium-201 and Technetium-99-m-HMPAO. Sjöholm H, Elmqvist D,
Rehncrona S, Rosén I, Salford LG. Acta Neurol Scand 91(1):66-70, 1995
128. Growth inhibition of rat glioma cells in vitro and in vivo by aspirin. Aas A.T., Brun A, Tönnesen TI, and
Salford LG. J of Neuro-Oncology 24:171-180, 1995
129. The RG2 rat glioma model. Aas AT, Blennow C, Brun A, Strömblad S and Salford LG. J of NeuroOncology 23:175-183, 1995
130. A comparative study on the pharmacokinetics and biodistribution of boronated porphyrin (BOPP) and
sulfhydryl boron hydride (BSH) in the RG2 rat glioma model. Ceberg CP, Brun A, Kahl SB, Koo MS, Persson
BRR and Salford LG. J of Neurosurgery 83:86-92, 1995
131. Performance of sulfhydryl boron hydride in patients with grade III and IV astrocytoma: a basis for boron
neutron capture therapy. Ceberg CP, Brun A, Persson A, Fyhr AS, Huiskamp R, Persson BRR and Salford LG.
J. Neurosurg 83:79-85, 1995
132. Necrosis of malignant gliomas after intratumoral injection of Thallium-201 in vivo in the rat. Sjöholm H,
Ljunggren K, Adeli R, Brun A, Persson RBR, Strand SE and Salford LG ca. Anti-Cancer Drugs 6:109-114,
1995
133. A stochaistic model for the subcellular dosimetry in Boron Neutron Capture Therapy. Ceberg CP, Persson
A, Brun A, Huiskamp R, Salford LG and Persson BRR. Phys Med Biol, 1995
134. Use of an enhanced gradient system for diffusion MR imaging with motion-artifact reduction. Brockstedt S,
Wirestam R, de Poorter J, de Wagter C, Salford LG, Holtås S, Ståhlberg F: Acta Radiol 36:662-670, 1995
135. SPECT imaging of gliomas with Thallium-201 and technetium-99m-HMPAO. Sjöholm H, Elmqvist D,
Rehncrona S, Rosén I and Salford LG. Acta Neurol Scand 1955 91:66-70
136. Hjärntumörer (Brain Tumours). Chapter in "Hjärnans Sjukdomar" ("Diseases of the Brain"). Ed.: Lennart
Widén, Tidens Förlag 419-435, 1995
137. Quantification of low-velocity motion using MR phase mapping with a navigator-echo technique for
reduction of motion artifacts: Application to intracranial dynamics in volunteers and patients with brain tumors.
Wirestam R, Salford LG, Thomsen C, Brockstedt S, Lilja Å , Henriksen O, Stå hlberg F. Magn Res Imaging
15:1-11 1995
1996
138. The structure and phylogeny of a new family of human endogenous retroviruses. Widegren B, Kjellman C,
Aminoff S, Salford LG, Sjögren HO. J. of General Virology 77:1631-1641, 1996
139. Enhanced cellular uptake of radiopharmaceuticals with electroporation.
I. Application with 111In-oxine. Engström P, Jonsson A-C, Persson BRR, Strand S-E, Salford LG. J Nucl Med
140. Foundations for boron neutron capture therapy of high-grade astrocytomas. Salford LG, Ceberg CP, Brun
A, Persson A, Persson RBR. In: Mishima (Ed.) Cancer Neutron Capture Therapy. Plenum Press, New York pp
227-232, 1996
141. Effect of electroporation on the targeting of Chinese hamster V79 lung fibroblast cells with indium 111labeled oxine. Engström P, Jonsson A-C, Persson BRR, Strand S-E, Salford LG. Tumour targeting 2:251-258,
1966
142. Permeability of the blood brain barrier in rats induced by continous wave and pulse-modulated 915 MHz
electromagnetic radiation exposure in TEM-cells. Persson BRR, Salford LG. In: Chiabrera A and Juutilainen J
(Eds) CEC-XIII-244/6/-96 edn. pp 66-72. Brussels: EU DG XIII, 1996
143. Albumin leakage through the blood- brain barrier in rats induced by continuous wave and pulse-modulated
915 MHz electromagnetic radiation exposure in TEM-cells. Persson BRR, Salford LG, Brun A. In: Prieur G and
Nadi M (Eds) Third Int Congr on the European Bio Electromagnetics Assoc. Nancy 1: L.I.E.N., Université
Henri Poincaré. 1996
144. Electropermeabilization in vivo, a new technique for brain tumour therapy and cell targeting. Salford LG,
Persson BRR, Ceberg C.P., Engström P, Brun A. In: Prieur G and Nadi M (Eds) Third Int Congr on the
European Bio Electromagnetics Assoc. Nancy 1: L.I.E.N., Université Henri Poincaré. 1996
145. Experimental studies of brain tumour development in rats during exposure to contiuous wave and pulse
modulated 915 MHz electromagnetic radiation exposure in TEM-cells. Salford LG. Persson RBR. In: Chiabrera
A and Juutilainen J (Eds) CEC-XIII-244/6/-96 edn. pp 73-78. Brussels: EU DG XIII, 1996
146. Experimental studies of brain tumour development in rats during exposure to continuous wave and pulse
modulated 915 MHz electromagnetic radiation in TEM-cells. Salford LG, Persson RBR, Persson L, Brun A. In:
Prieur G and Nadi M (Eds) Third Int Congr on the European Bio Electromagnetics Assoc. Nancy 1: L.I.E.N.,
Université Henri Poincaré. 1996
1997
147. Neurological aspects on wireless communication. Salford LG, Persson RBR, Brun A. WHO publication. Ed
Repacholi. 1997
(Eff. Non-Therm. Pulsed and Amplitude Modulated RF EM Fields and Related
Health Risks. 3/97 J. H. Bernhardt, R. Matthes, & M. H. Repacholi, eds.,
International Commission of Non-Ionizing Radiation Protection and World
Health Organization, Proc. Sem on Biol. Munich Germany Nov 20 and 21, 1996, pp. 131-144).
148. Blood-brain barrier permeability in rats exposed to electromagnetic fields used in wireless communication.
Persson BRR, Salford LG, Brun A. Wireless Networks Journal 3:455-461, 1997
149. Brain tumour development in rats exposed to electromagnetic fields used in wireless communication.
Salford LG, Brun A, Persson BRR. Wireless Networks Journal. 3:463-469
150. Whole body hyperthermia and ADPRT inhibition in experimental glioma treatment. Salford LG, Brun A,
Kjellén E, Pero R, Persson RBR. NY Acad Sci. 835:192-202, 1997
151. Neurokirurgi i forntid och framtid. Salford L.G. I Lundaforskare föreläser, Lund University Press 29:59-67,
1997
152. Early mental changes in patients with astrocytomas with special reference to anxiety and epilepsia. Lilja Å ,
Salford LG. Psychopathology 30:316-323, 1997
1998
153. Psychodynamics and Cancer: Percept genetic methods applied in patients with brain tumours. Lilja Å,
Smith G, Salford L. Chapter in: First Nordic Symposium on Research into Rorshach and Projective Methods.
(Ed Carlsson AM et al). pp 103-116, 1998
154. Effect of high voltage pulses on survival of Chinese hamster V79 lung fibroblast cells. Danfelter M,
Engström P, Persson BRR and Salford LG. Bioelectrochemistry and Bioenergetics 47:97-101, 1998
155. Dynamic gamma camera studies of 111 In-bleomycin complex in normal and glioma bearing rats after in
vivo electropermeabilization using exponential high-voltage pulses. Engström P, Persson BRR and Salford LG.
Bioelectrochemistry and Bioenergetics 46:241-248, 1998
156. Lilja Å, Smith GJW, Malmström P, Salford LG, Idvall I: Psychological
profile related to malignant tumours of different histopathology.
Psycho-Oncology 7; 376-386, 1998.
157. The design of a small anechoid chamber for biomedical research and study on effects of electromagnetic
fields on the blood-brain barrier. Malmgren, L., Persson, B. R. R., Brun, A., & Salford, L. G. 1998, " in
Radiofrequency Systems for NMR Imaging: Coil development and studies of non-thermal biological effects
(Techn. Dr. Thesis), L. Malmgren, ed., Dept of Applied Electronics, Lund University, Box 118, SE-221 00
Lund, Sweden, pp. 1-9.
158. Effect of high-voltage electrical pulses on subcutaneous glioma tumours on rats. Engström P, Persson BRR
and Salford LG. Bioelectrochemistry and Bioenergetics 47:163-166, 1998
159. Attitude towards agression and creative functioning in patients with breast cancer. Lilja Å , Smith G,
Malmström P, Salford LG.
Perceptual and Motor Skills 87:291-303, 1998
1999
160. Studies of in vivo electropermeabilization by gamma camera measurements of (99m) Tc-DTPA.. Engström
PE, Persson BR, Salford L.G. Biochem Biophys Acta Dec 27;1473(2-3):321-8, 1999
161. Frontal lobe dysfunction in patients with non-frontal malignant gliomas. A monoaminergic dysregulation?
Lilja Å , Skagerberg G, Salford LG.
Medical Hypothesis 53:190-193, 1999
162. HERV-F (XA34) is a full length human endogenous retrovirus expressed in placental and fetal tissues.
Kjellman CH, Sjögren HO, Salford LG and Widegren B. Gene. Oct 18;239(1):99-107, 1999
163. Calcium efflux of Plasma Membrane Vesicles Exposed to ELF Magnetic fields-A test of the ion parametric
resonance model. Bauréus, C. C. L., Sommarin Marianne, Persson, B. R. R., Salford, L. G., & Eberhardt, J. L.
1999 BEMS 21st Annual Meeting, Long Beach, CA no. 13-4, pp. 74-75.
2000
164. Electroporation - a new possibility in Boron Neutron Capture Therapy?
Ceberg C and Salford LG. Int J Radiat Oncol Biol Phys 2000 Feb 1;46(3):685-6
165. The Studsvik BNCT Project: Structure and The Proposed Protocols. Capala J., Henriksson R., H.-Stenstam
B. Salford L., Carlsson J. and Sköld K. In: Proceedings of the Ninth International Symposium on Neutron
Capture Therapy for Cancer. Osaka, Japan, October, 2000.
166. Expression of TGF-beta isoforms, TGF-beta receptors and Smad molecules at different stages of human
glioma. Kjellman C, Olofsson S, Hansson O, von Schantz T, Lindvall M, Nilsson I, Salford L.G., Sjögren H-O,
and Widegren B. Intl J. Cancer, 2000, 89(3):251-8.
2001
167. Electric Bio-Impedance Dispersion in tissue after in vivo electropermeabilization. Persson, B. R. R., Blad,
B., & Salford, L. G. in XI International Conference on Electrical Bio-Impedance, S. Grimnes, Ø. G. Martinsen,
& H. Bruvoll, eds., Nordic Electrical Bio-Impedance Club -NEBIC, Oslo, pp. 35-38 2001.
168. Téléphonie mobile et barriere Sang-cerveau (in french) Mobile Communication and the Blood-Brain
Barrier. Salford, L. G., Persson, B. R. R., Malmgren, L., & Brun, A. in Telephonie Mobile: Effets potentiels sur
la santé des ondes électromagnétiques de hautes fréquences, P. Lannoye, ed., Marco Pietteur, B-4053 Embourg,
Belgique, pp. 141-152. 2001.
169. Expression of the IL-6 family cytokines in human brain tumors. Lilja A, Nordborg C, Brun A, Salford LG,
Åman P. Int J Oncol. 2001 Sep;19(3):495-9
170. Electrically mediated drug delivery for treatment of an adenocarcinoma transplanted into rat liver.
Engström, P. E., Ivarsson, K., Tranberg, K-G., Stenram, U., Salford, L. G., & Persson, B. R. R. Anticancer
Research, vol. 21,no. 3, pp. 1817-1822, 2001.
171. A new antitumor treatment combining radiation and electric pulses. Engström, P. E., Persson, R. B. R.,
Brun, A., & Salford, L. G. Anticancer Research, vol. 21,no. 3, pp. 1809-1816, 2001.
172. Field cycling 1H-relaxation dispersion in model systems for immobilized proteins, and in normal and
pathological brain tissues. Persson, B. R. R., Dobre, C., Malmgren, L., & Salford, L. G.," in International
Symposium on Electromagnetics in Biology and Medicine, S. Ueno, ed., URSI Commission K:
Electromagnetics in Biology and Medicine, Co-sponsored by The Bioelectromagnetics Society (BEMS), Tokyo,
2001.
173. Electric Bio.Impedance Dispersion in tissue after in vivo electropermeabilization Persson, B.. R. R., Blad,
B., & Salford, L. G. in XI International Conference on Electrical Bio-Impedance, S. Grimnes, Ø. G. Martinsen,
& H. Bruvoll, eds., Nordic Electrical Bio-Impedance Club -NEBIC, Oslo, pp. 35-38, 2001.
2002
174. Selective inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats
immunized with IFN-
Salford, LG, and Siesjö, P. In
Hegardt P, NO Immunosuppresion and Tumour Immunotherapy, dissertation Lund University 2002 (ISBN 91628-5089-X)
175. Creativity and breast cancer. A study of premenopausal women. Smith GJW, Lilja Å, Malmström P,
Salford LG. Creativity Research Journal
176. Search for effective therapy against glioblastoma multiforme - clinical immunisation with autologous
glioma cells transduced with the human Interferon-
B. R. R., Larsson, E.-M., Lindvall, M., Visse, E., & Widegren, B. in Developments in Neuroscience, Excerpta
Medica, Int. Congr. Ser. 1247, Elsevier, Ed. K. Watanabe, 2002 pp 211-220
2003
177. Boron Neutron Capture Therapy for Glioblastoma Multiforme: Clinical Studies in Sweden.
Capala, J, Stenstam, B. H., Sköld, K., Munck af Rosenschöld, P., Giusti, V., Persson, C., Wallin, E., Brun, A.,
Franzén, L., Carlsson, J., Salford, L.G., Ceberg, C., Persson, B.R.R., Pellettieri, L. and Henriksson, R. 2002 J
Neurooncol. 2003 Mar-Apr;62(1-2):135-44.
178. Nerve cell damage in mammalian brain after exposure to microwaves from GSM mobile phones. Salford
LG, Brun AE, Eberhardt JL, Malmgren Lars and Persson BRR. Environmental Health Perspectives, On-line Jan
29 2003. DOI # 10.1289/ehp.6039, in print: Environmental Health Perspectives 2003 111(7): 881-883
179. Interaction between weak low frequency magnetic fields and cell membranes. Bauréus Koch CLM,
Sommarin M, Persson BRR, Salford LG and Eberhardt JL. Bioelectromagnetics 24:395-402
180. A model for evaluating therapeutic response of combined cancer treatment modalities: Applied to treatment
of subcutaneously implanted brain tumors (N32 and N29) in Fischer rats with pulsed electric fields (PEF) and
60Gamma Radiation (RT). Bertil R. R. Persson, Ph.D.1,3,*Catrin Bauréus Koch, M.Sc.1,3Gustav Grafström,
MSc.1Per E. Engström, Ph.D.1Leif G. Salford, M.D., Ph.D.2,3 TCRT Oct 2003
181. Psychological profile in patients with Stages I and II breast cancer: associations of psychological profile
with tumor biological prognosticators. Lilja A, Smith G, Malmstrom P, Salford LG, Idvall I, Horstman V.
Psychol Rep. 2003 Jun;92(3 Pt 2):1187-98.
2004
182. Identification and characterization of a human smad3 splicing variant lacking part of the linker region.
Kjellman Ch, Honeth G, Järnum S, Lindvall M, Darabi A, Nilsson I, Edvardsen K, Salford LG, Widegren B.
Gene 327:141-152 2004
183. Quality assurance of patient dosimetry in boron neutron capture therapy. Per M. Munck af Rosenschöld,
Jacek Capala, Crister P. Ceberg, Valerio Giusti, Leif G. Salford and Bertil R. R. Persson Acta Oncol.
2004;43(4):404-11.
184. Radiation sterilisation of cultured human brain tumour cells for clinical immune tumour therapy. BaureusKoch C, Nyberg G, Widegren B, Salford LG, Persson BR. Br J Cancer. 2004 Jan 12;90(1):48-54.
185. Kombinerad immun- och genterapi mot elakartade hjärntumörer hos människa, baserad på våra
forskningsresultat i djurförsök. - BRIGTT projektet (BRain Immuno Gene Tumour Therapy) vid
Rausinglaboratoriet, Neurokirurgiska kliniken och Tumörimmunologen
Salford LG. Populärvetenskaplig uppsats för Region Skånes rapport 2004 över Merkostnadsbidragsstödd
forskning. 2004
186. Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an
approach for improvement of gene delivery to brain tumours. Skog J, Edlund K, Widegren B, Salford LG,
Wadell G, Mei YF.
J Gen Virol. 2004 Sep;85(Pt 9):2627-38.
187. Absorbed dose distribution in glioma tumors in rat brain after therapeutic intratumoral injection of 201Tlchloride.
Ljunggren K, Liu X, Erlandsson K, Ljungberg M, Salford L, Strand SE. Cancer Biother Radiopharm. 2004
Oct;19(5):562-9
2005
188. Oncostatin M signaling in human glioma cell lines. Krona A, Jarnum S, Salford LG, Widegren B, Aman P.
Oncol Rep. 2005 May;13(5):807-11.
189. Long-term mobile phone use and brain tumour risk LönnS, Ahlbom A, Hall P, Feychting M and The
Swedish INTERPHONE Study Group: Bergenheim T, Damber L, Malmer B, Boethius J, Flodmark O,
Langmoen I, Lilja A, Mathiesen T, Ohlsson Lindblom I, Stibler H, Lycke J, Michanek A, Pellettieri L, Möller T
and Salford L. American Journal of Epidemiology 2005 161(6):526-535
190. Activation of purified allogeneic CD4+ T cells by rat bone marrow-derived dendritic cells induces
concurrent secretion of IFN-gamma, IL-4 and IL-10. Janelidze S, Visse E, Enell K, Darabi A, Salford LG,
Siesjö, P. Immunology Letters. 2005 Nov 15;101(2):193-201
191. Immunisation with autologous glioma cells transfected with IFN-g gene significantly prolongs survival in
GBM-patients older than 50 years. Salford LG1,2, Ask E3, Siesjö P1,2 S 1,2, Skagerberg G1,2 Bauréus Koch C 4,2,
Blennow C1,2,Darabi A1,2, Elfgren C5, Englund E6, Janelidze S1,2, Larsson E-M7, Lilja Å1, Persson BRR4,2,
Rydelius A1,3, Strömblad S1,2,Visse E1,2 and Widegren B7. Neuro-Oncology July 2005, p 370.
192. Immunotreatment in patients with glioblastoma multiforme – a histopathological evaluation of reactive and
inflammatory changes. Persson A, Skagerberg G, Salford LG, Englund E. Clin Neuropathol. 2005 SepOct;24(5):201-8.
2006
193. Exposure of rat brain to 915 MHz GSM microwaves induces changes in gene expression but not double
stranded DNA breaks or effects on chromatin conformation. Igor Belyaev, Catrin Bauréus Koch, Olle Terenius,
Katarina Roxström-Lindquist, Lars Malmgren, Wolfgang Sommer, Leif G. Salford, Bertil Persson.
Bioelectromagnetics 27:295-306 (2006)
194. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase
expression in single living cancer cells. Edqvist AH, Rebetz J, Järås M, Rydelius A, Skagerberg G, Salford LG,
Widegren B, Fan X. Mol Ther. 2006 Jul;14(1):139-48 ; [Epub ahead of print]
195. Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression. Järås M,
Edqvist A, Rebetz J, Salford LG, Widegren B, Xiaolong Fan.
Blood. 2006 Aug 1;108(3):1084-91.
196. Glioma stem cells: Evidence and limitation. Xiaolong Fan; Leif G. Salford,; Bengt Widegren, Semin
Cancer Biol. 2006 May 4; Epub ahead of print, 2007 Jun; 17(3):214-18
197. Dynamic susceptibility contrast-enhanced perfusion magnetic resonance (MR) imaging combined with
contrast enhanced MR imaging in the follow-up of immuno-gene treated glioblastoma multiforme. Stenberg L,
Englund E, , Wirestam R, Siesjö P, Salford LG, Larsson E-M. Acta Radiol. 2006 Oct;47(8):852-61..
198. Women with left frontal glioblastoma have a significantly shorter survival – Why?
Leif G. Salford, Erik Nordenström, Gunnar Skagerberg, Torgil Möller, Bengt Widegren and Roland Perfekt
Neuro-Oncology, October 2006 Vol 8 (4) 290-291
199. Risk of brain tumors associated with exposure to exogenous female sex hormones. Annette Wigertz¹,
Stefan Lönn¹, Tiit Mathiesen², Anders Ahlbom¹, Per Hall³, Maria Feychting¹, and the Swedish Interphone Study
Group: Bergenheim T, Damber L, Henriksson R, and Malmer B (Umeå University Hospital), Boethius J,
Flodmark O, Langmoen I, Lilja A, Ohlson I, and Stibler H (Karolinska University Hospital), Lycke J, Michanek
A, and Pellettieri L (Sahlgrenska University Hospital), Möller T and Salford L (Lund University Hospital)
Am J Epidemiol. 2006 Jul 11; [Epub ahead of print
200. 99mTc DTPA uptake and electrical impedance measurements. Grafström G, Engström P, Salford LG,
Persson BRR Cancer Biother Radiopharm. 2006 Dec;21(6):623-35.
201. The Benevento Resolution, 31 scientists incl Leif G. Salford
Electromagnetic Biology and Medicine 2006: EBM 25(4).
202. Coxsackievirus and adenovirus receptor expression in non-malignant lung tissues and clinical lung cancers.
Wang Y, Wang S, Bao Y, Ni C, Guan N, Zhao J, Salford LG, Widegren B, Fan X. J Mol Histol. 2006
May;37(3-4):153-60. Epub 2006 Sep 22.
2007
203. Synergism between GM-CSF and IFN- : Enhanced immunotherapy in mice with glioma. Smith KE.,
Janelidze S., Badn W., Salford L.G, Siesjö P., Visse E. and Darabi A. Int. J. Cancer. 2007 Jan 1;120(1):75-80
204. Genetic intra-tumour heterogeneity in high-grade tumours is associated with telomere-dependent mitotic
instability. Christine Glanz1,2, Johan Rebetz1-3, Ylva Stewénius4, Annette Persson5, Elisabet Englund5, Nils
Mandahl, Fredrik Mertens, Leif G. Salford 1, Bengt Widegren1-3, Xiaolong Fan1,2,6 , and David Gisselsson4
Neuropathology and Applied Neurobiology 2007 Aug;33(4):440-54.
205. Non-Thermal Effects of EMF upon the Mammalian Brain – the Lund Experience. Salford LG, Nittby H,
Brun A, Grafström G, Eberhardt JL, Malmgren L, Persson BRR. The Environmentalist. Epub Nov 07
206. Microarray analysis of gliomas reveals grade-specific and chromosomal position-associated expression
signatures and identifies potential immunotherapy targets. Persson O, Krogh M, Saal L, Englund E, Liu J,
Parsons R, Mandahl N, Borg Å, Widegren B, Salford LG. J Neurooncol. 2007 Oct;85(1):11-24. Epub 2007 Jul
17
207. Neuroblastomas and medulloblastomas exhibit more coxsackie adenovirus receptor expression than gliomas
and other brain tumours. (NEU-06-0035) Annette Persson, Biomed Sc1, Xiaolong Fan, MD PhD2, Leif G
Salford, MD Professor 4, Bengt Widegren, Professor2,3 and Elisabet Englund, MD PhD1 Neuropathology. 2007
Jun;27(3):233-6.
208. Lentiviral vector mediated siRNA knock-down of hTERT results in diminished capacity in invasiveness
and in vivo growth of human glioma cells in a telomere length-independent manner. Zhao P, Wang C, Fu Z, You
Y, Cheng Y, Lu X, Lu A, Liu N, Pu P, Kang C, Salford LG, Fan X. Int J Oncol. 2007 Aug;31(2):361-8.
209. Selective inhibition of inducible nitric oxide synthase enhances anti-tumor immune responses in rats
immunized with IFN-gamma secreting glioma cells. Badn W., Hegardt P., Larsson M., Darabi A., Esbjörnsson
M., Janelidze S., Salford LG., Visse E. and Siesjö P, J Immunol. 2007 Sep 15;179(6):4231-8.
210. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized
with IFN-gamma-secreting glioma cells.
Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö
P. Scand J Immunol. 2007 Mar;65(3):289-97.
211. Postimmunization with IFN-gamma-secreting glioma cells combined with the inducible nitric oxide
synthase inhibitor mercaptoethylguanidine prolongs survival of rats with intracerebral tumors.
Badn W, Visse E, Darabi A, Smith KE, Salford LG, Siesjö P. J Immunol. 2007 Sep 15;179(6):4231-8
212. Low dose Zebularine treatment enhances immunogenicity of tumor cells. Liu H, Xue ZT, Sjogren HO,
Salford LG, Widegren B. Cancer Lett. 2007 Nov 8;257(1):107-15.
213. Hjärntumörer (Brain Tumours). Chapter in "Hjärnan" (”The Brain")
Textbook. Karolinska Institutet University Press AB ISBN I978-91-85565-13-9
214. Cognitive impairment in rats after long-term exposure to GSM-900 mobile phones. Nittby H, Grafström G,
Tian D, Brun A, Persson BRR, Salford LG, Eberhardt J. Bioelectromagnetics,
2007 Nov 28; [Epub ahead of print
215. Inhibition of inducible nitric oxide synthase enhances anti-tumour immune responses in rats immunized
with IFN-gamma-secreting glioma cells.
Badn W, Hegardt P, Fellert MA, Darabi A, Esbjörnsson M, Smith KE, Janelidze S, Salford LG, Visse E, Siesjö
P. Scand J Immunol. 2007 Mar;65(3):289-97.
2008
216. Regional cerebral metabolic rate (positron emission tomography) during inhalation of nitrous oxide 50% in
humans. Reinstrup P, Ryding E, Ohlsson T, Sandell A, Erlandsson K, Ljunggren K, Salford LG, Strand S, Uski
T. Br J Anaesth. 2008 Jan;100(1):66-71. Epub 2007 Nov 23.
217. Radiofrequency and Extremely Low Frequency Electromagnetic Fields’ Effects upon the Blood-Brain
Barrier. Henrietta Nittby, Gustav Grafström. Jacob L. Eberhardt. Lars Malmgren. Arne Brun, Bertil R.R.
Persson, Leif G. Salford Electromagnetics in biology and medicine 2008, 27(2):103-126
218. "Thirty years war against malignant glioma" In honour of professor Jun Yoshida, Dept of Neurosurgery,
Nagoya, Japan, 2008 by Leif G. Salford. Chapter in Proceedings Nagoya Univ, Japan
219 Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage
differentiation potential in high-grade glioma. Rebetz J, Tian D, Persson A, Widegren B, Salford LG, Englund
E, Gisselsson D, Fan X. PloS ONE 0802
220. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a
prolonged high-dose of boronophenylalanine (BPA). Henriksson R, Capala J, Michanek A, Lindahl SK, Salford
LG, Franzén L, Blomquist E, Westlin JE, Bergenheim AT. Radiother Oncol. 2008 Mar 10 [Epub ahead of print]
221. Exposure to Radiation from Global System for Mobile Communications at 1800 MHz Significantly
Changes Gene Expression in Rat Hippocampus and Cortex. Henrietta Nittby, Bengt Widegren, Morten Krogh,
Gustav Grafström, Gustav Rehn, Henrik Berlin, Jacob L. Eberhardt, Lars Malmgren, Bertil R.R. Persson and
Leif G. Salford. The Environmentalist (2008) 28: 458-465.
222. The mammalian brain in the electromagnetic fields designed by man - with special reference to blood-brain
barrier function, neuronal damage and possible physical mechanisms. Leif G. Salford, Henrietta Nittby, Arne
Brun, Gustav Grafström, Lars Malmgren, Marianne Sommarin, Jacob Eberhardt, Bengt Widegren and Bertil
R.R. Persson. Progress in Theoretical Physics Suppl. 2008, 174:283-309
223. Theoretical aspects of interaction between weak electromagnetic fields (from mobile phones, base stations
and powerlines) and the living cell. Halgamuge MN, Persson BRR, Salford LG, Mendis P and Eberhardt JL.
IEEE Comm. Magazine 18/3 2008
224 Proteomic expression analysis and comparison of protein and mRNA expression profiles in human
malignant gliomas Persson O , Brynnel U, Levander F, Widegren B, Salford LG, Krogh M. Proteomics –
Clinical Applications 2009 Jan;3(1):83-94. doi: 10.1002/prca.200800086. Epub 2008 Nov 20.
225. Blood-brain barrier permeability and nerve cell damage in the rat brain 14 and 28 days after exposure to
microwaves from GSM mobile phones. Eberhardt J, Persson BRR, Malmgren L, Brun A, Salford LG
Electromagnetics in biology and medicine. (2008) 27: 215-29
226. Histopathological examinations of rat brains after long-term exposure to GSM-900 mobile phone radiation
Grafström G, Nittby H, Brun A, Persson BRR, Salford LG, Eberhardt J. Brain Research Bulletin 77/5 pg. 257263
227. Survival of rats with N29 brain tumours after irradiations with 5 or 15 Gy and immunization with IFNgamma secreting tumour cells. Persson BRR, Bauréus Koch C, Grafström G, Ceberg C, Munck af Rosenschöld
P, Widegren B and Salford LG. IEEE 2008 Int Conf on BioMedical Engineering and Informatics. P.243-247
2009
228. Glioma stem cells in the context of oncogenesis. Johan Bengzon, Elisabet Englund, Leif G. Salford and
Xiaolong Fan. Book chapter in: Cancer drug discovery and development: Stem cells and cancer. Editors:
Bagely RG and Teicher BA. Humana Press, 2009 pp. 115-126.
229. Increased blood-brain barrier permeability in the mammalian brain seven days after exposure to the
radiation from a GSM-900 mobile phone. Henrietta Nittby1, Arne Brun2, Jacob Eberhardt3, Lars Malmgren4,
Bertil R.R. Persson3, Leif G. Salford1 Pathophysiology. 2009 Aug;16(2-3):103-12. Epub 2009 Apr 2.
230. Microarray and proteomic analysis of Gliomas – Identification of possible targets.
Bengt Widegren1,2, Oscar Persson1, Xiaolong Fan1, and Leif G. Salford 1
Book chapter In “Therapeutic RNAs for brain tumor treatment” Ed. Jan Barciszewski et al. 2009
231. Immunizations with IFN-gamma secreting tumor cells can eliminate fully established and invasive rat
gliomas. Janelidze S, Bexell D, Badn W, Darabi A, Enell Smith K, Englund W, Gunnarsson S, Milos P, Persson
A, Salford LG, Siesjö P, Visse E. J. Immunother. 2009 Jul-Aug;32(6):593-601
232. Fiber mediated receptor masking in non-infected bystander cells restricts adenovirus cell killing effect but
promotes adenovirus host co-existence. Rebetz J, Na M, Su C, Holmqvist B, Edqvist A, Nyberg C, Widegren B,
Salford LG, Sjögren HO, Arnberg N, Qian Q, Fan X. PLoS One. 2009 Dec 29;4(12):e8484.
233. Vägen hit – källor till kunskap och utveckling. Tankar och betraktelser av emeriti 2009. Med fak, Lunds
Universitet, 2009. Kapitel, pp 29-53.
234. Comparison Between Two Models for Interactions Between Electric and Magnetic Fields and
Proteins in Cell Membranes Malka N. Halgamuge, Bertil R.R. Perssont, Leif G. Salford, Priyan
Mendis, Jacob Eberhardt. Environmental Engineering Science. October 2009, Vol. 26, No. 10: 14731480
2010
235. Distribution, cellular localization, and therapeutic potential of the tumor-associated antigen Ku70/80 in
glioblastoma multiforme. Persson O, Salford LG, Fransson J, Widegren B, Borrebaeck CA, Holmqvist B.
J Neurooncol. 2010 Apr;97(2):207-15. Epub 2009 Oct 7
236. Effects of Microwave Radiation upon the Mammalian Blood-Brain Barrier
Salford LG, Nittby H, Brun A, Eberhardt J, Malmgren L, Persson BRR In “Non-thermal effects and
mechanisms of interaction between electromagnetic fields and living matter” RAMAZZINI INSTITUTE EUR.
J. ONCOL. LIBRARY Volume 5, Eds Giuliani L and Soffritti M. 2010, p. 333-356
237. Plasma proteome profiling reveals prognostic cytokine pattern in glioblastoma multiforme patients
undergoing immunization therapy. Anders Carlsson, Oscar Persson, Christer Wingren, Bengt Widegren, Leif G
Salford, Carl AK Borrebaeck. Proteomics Clin Appl. 2010 Jul;4(6-7):591-602.
238. Radiation Immunomodulatory Gene Tumor Therapy of rats with intracerebral glioma tumors.
Bertil R.R. Persson1,4), Catrin Bauréus Koch2,4), Gustav Grafström1,4), Crister Ceberg1,4), Per Munck af
Rosenschöld1,4), Henrietta Nittby2,4), Bengt Widegren3,4) and Leif G. Salford2,4)
Radiat Res. 2010 Apr;173(4):433-40
239. Tumour response from immunization with interferon-gamma (IFN-gamma) transfected syngeneic tumour
cells combined with radiation therapy in rats with contra-lateral tumours. PERSSON, B. R. R., BAURÉUS
KOCH, C., GRAFSTRÖM, G., CEBERG, C., NITTBY, H., WIDEGREN, B. & SALFORD, L. G. Cancer
Therapy 8A 2010 (on line www.cancer-therapy.org)).
2011
240. The development of echo-encephalography in Sweden
Leif G. Salford Chapter in textbook “Ultrasound in Clinical Diagnosis” eds Eklöf, Lindström and Persson
Oxford Press. pp 43-49
241. Non-thermal GSM RF and ELF EMF effects upon rat BBB permeability. Henrietta Nittby, Arne Brun,
Susanne Strömblad, Mehri Kaviani, Wenjun Sun, Lars Malmgren, Jacob Eberhardt, Bertil R. Persson, Leif G.
Salford. The Environmentalist 2011 Vol 31, 2, p.140-148 .
242. Rat Multipotent Mesenchymal Stromal Cells Lack Long-Distance Tropism to Three Different Rat Glioma
Models. Daniel Bexell M.D., Ph.D.1*, Salina Gunnarsson Ph.D.1, Andreas Svensson1, Ariane Tormin Ph.D.2,
Catarina Henriques-Oliveira3, Peter Siesjö M.D. Ph.D.1, Gesine Paul M.D., Ph.D. 3,4, Leif G. Salford M.D.
Ph.D.1, Stefan Scheding M.D. Ph.D. 2,5, Johan Bengzon M.D. Ph.D. Neurosurgery 2011 Aug 19 [Epub ahead
of print]
243. “Abscopal” Effect of Radiation Therapy Combined with Immune-Therapy Using IFN-gamma; Gene
Transfected Syngeneic Tumor Cells, in Rats with Bilateral Implanted N29 Tumors," Bertil R. Persson, Catrin
Bauréus Koch, Gustav Grafström, Crister Ceberg, Per Munck af Rosenschöld, Henrietta Nittby, Bengt
Widegren, Leif G. Salford. ISRN Immunology, vol. 2011, Article ID 230130, 13 pages, 2011
2012
244. Analgetic Effects of non-thermal GSM RF EMF in the Land Snail Helix Pomatia. Nittby H, Kaviani M,
Sun W, Malmgren L, Eberhardt J, Persson BR, Salford LG. Int J Radiat Biol. (2012) 88:245-52.
245. Paramagnetic ions affect relaxation rate dispersion of blood: Implications for Magnetic Resonance
Relaxation Dispersion Imaging. Bertil R.R. Persson, Lars Malmgren and Leif G. Salford. Acc for publ. in
Journal of Bioengineering and Biomedical science
246. An epigenetic mechanism for high, synergistic expression of indoleamine 2,3-dioxygenase 1 (IDO1) by
combined treatment with Zebularine and IFN gamma. Potential therapeutic use in autoimmune diseases.
Xue Z, Sjögren HO, Salford LG, Widegren B. Mol Immunol. 2012 Jun;51(2):101-11. Epub 2012 Mar 17.
247. Hjärntumörer (Brain Tumours). Chapter in "Hjärnan" (”The Brain")
Textbook. Karolinska Institutet University Press AB ISBN I978-91-85565-13-9
248. Mobile telephony and the brain – the effects of non-thermal radio frequency electromagnetic fields upon
biology. Leif G. Salford (in collaboration with Henrietta Nittby, Gustav Grafström, Jacob L. Eberhardt, Lars
Malmgren, Arne Brun and Bertil R.R. Persson). Chapter in the Norwegian Academy of Technological Sciences
(NTVA) 2011 Yearbook.
249. Calcium Efflux of Plasma Membrane Vesicles exposed to ELF Magnetic Fields – Test of a Nuclear
Magnetic Resonance Interaction Model. W.J. Sun, M. Kaviani Mogadam, M. Sommarin, H. Nittby, L.G.
Salford, B.R.R. Persson and J.L. Eberhardt Bioelectromagnetics 33:535-542 (2012)
250 Photon activation therapy of RG2 glioma carrying Fischer rats using stable thallium and monochromatic
synchrotron radiation
Crister Ceberg PhD1, Bo-Anders Jönsson PhD1, Yolanda Prezado PhD2 Tobias Pommer MS1, Henrietta Nittby
MD PhD3, Elisabet Englund MD PhD4, Gustav Grafström PhD1 Anneli Edvardsson1, Anna Stenvall1, Susanne
Strömblad3, Karin Wingårdh1, Bertil Persson PhD1 Hélène Elleaume PhD2,5, Bo Baldetorp PhD6, Leif G.
Salford MD PhD3, Sven-Erik Strand PhD1Acc for publ. in Phys. Med. Biol Nov 2012
251. Studies of 1H-NMR Relaxation Dispersion in Human Brain tissue Samples for Implementation of Magnetic
Resonance Relaxation Dispersion Imaging (MARDI).
Bertil R.R. Persson, Lars Malmgren and Leif G. Salford.
Acta Scientiarum Lundensia 2012 , Vol. 2012-001, pp. 1-22, ISSN 1651- 5013
252. Effects of Electromagnetic Fields from Wireless Communication upon the Blood-Brain Barrier
Leif G. Salford, Henrietta Nittby and Bertil R.R. Persson. BioInitiative 2012 Chapter 10, pp 1-52
2013
253. Better prognosis of patients with glioma expressing FGF2-dependent PDGFRA expression irrespective of
morphological diagnosis. Dongfeng Chen; Annette Persson; Yingyu Sun; Leif G Salford; David Gisselsson
Nord; Elisabet Englund; Tao Jiang; Xiaolong. PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4,
p 1-14. |e61556
254. Treatment of brain tumours with electroporation and bleomycin in an in vivo rat model. Ljungvall M.,
Salford, L. G., and Persson, B. R. R., (2013). (Master Thesis Med. Magnus Ljungvall, autumn 2000; sem.11),
Acta Scientiarum Lundensia, Vol. 2013-001, pp 1-10, ISSN 1651-5013
Effect of Zebularine Treatment in a Diabetes Model of Allotransplanted Pancreatic Islets.
Nittby H, Ericsson P, Förnvik K, Strömblad S, Jansson L, Xue Z, Skagerberg G, Widegren B, Sjögren HO,
Salford LG Subm. Acc after revision PLOS ONE
Submitted
Co-expression modules of EGFR and PDGFRA define distinct glioma entities.
Yingyu Sun, Wei Zhang, Dongfeng Chen, Junxiong Zheng, Henrik Lilljebjörn, Yuhong. Lü,Zhaoshi Bo,
Charlotte Soneson, Hans Olov Sjogren, Leif G. Salford, Thoas Fioretos, Tao Jiang, and Xiaolong Fan. Submitted
Manuscript
Synergistic induction of IDO1 expression by the DNA demethylating agent Zebularine in combination with
interferon gamma and/or other agents. Ericsson P, Jansson L, Xue Z, Nittby H, Förnvik K, Widegren B, Salford
LG, and Sjögren HO. Manuscript
Zebularine treatment of lymphoid cell cultures induces tryptophan degradation via IDO1 kynureninase
upregulation. Widegren B, Ericsson P, Förnvik K, Liu H, Nittby H, Xue ZT, Salford LG, Sjögren HO.
Manuscript in preparation
Transcription factors involved in the interaction with CCW(A/T)GG pentanucleotides in the promoters of
mammalian and viral DNA. Xue ZT, Liu H, Salford LG, Widegren B. Manuscript in preparation
Simultaneous Registrations of fRMI and EEG during the Multi-Source Interference Task
Henrietta Nittby1,2, Jodi Miller1, John Robertson1, Nicole Juen1, Ronnie Abi-Raad1, Mikael Johansson3, Leif G.
Salford2, Frank Prato1, Alex Thomas1 Manuscript
MEK inhibitors affect the steady state trafficking of PDGFRA and EGFR in human primary glioma cells
Dongfeng Chen, Duo Zuo, Annette Persson, Manli Na, Leif G. Salford, Xiaolong Fan, Enming Zhang
Manuscript